Delivery Order SPE2DB22D2206-SPE2DB24FGR03
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Tobramycin 300 mg/5 ml ampules. The contract has a potential value of $4,188.53 and a completion date of January 31, 2024. Amerisourcebergen Drug Corp serves as a prime contractor for DLA Troop Support Medical, providing a range of pharmaceutical products and medical supplies to support military treatment programs. This...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $35,434.99 firm fixed-price delivery order is for the supply of Tobramycin 300 mg/4 ml ampules, a critical antibiotic medication. The contract has an ultimate completion date of May 15, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, the Corporate Office division of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The $4,119.26 firm fixed price contract is for the supply of 4,558,749,565 units of the drug Tobramycin 300 mg/5 ml ampules. This order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued up to $999,999,999.00...
- The Defense Logistics Agency awarded a delivery order valued at $3,061.26 to AmerisourceBergen Drug Corp for Tobramycin 1.2 GM vials, a critical antibiotic pharmaceutical product. This contract was competitively awarded on November 5, 2025, with an ultimate completion date of November 6, 2025, and utilizes firm fixed pricing with no set-aside designation. The work will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order represents a...
- This federal contract award is for the delivery of Tobramycin 1.2 GM vials to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on March 25, 2025, with a ceiling value of $1,888.72. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of March 26, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a...
- This is a $1,023.08 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order is for Tobramycin-Dexameth Ophth Susp 5ML, a pharmaceutical product, with a period of performance through May 19, 2025. The contract is not set aside and was competitively awarded. Amerisourcebergen Drug Corp holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for $3,528.72. This order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00, which serves as the primary vehicle for Amerisourcebergen to provide pharmaceuticals, medical supplies, and related distribution services to support Department of Defense military treatment programs...
- The Defense Logistics Agency (DLA) awarded a firm fixed price Delivery Order contract worth $1,182.71 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. This delivery order is for the supply of pharmaceutical products, including a 0.25% 10ML medication, to support military treatment programs and facilities. The contract has a completion date of March 28, 2024. Amerisourcebergen Drug Corp is the prime contractor and holds an Indefinite Delivery Contract (IDC) with DLA,...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide pharmaceutical products and medical supplies valued at $16,725.44. The contract has a performance period through March 22, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA Troop Support Medical valued up to...
- The U.S. government agency the Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract valued at $1,624.80 to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB24FGR03Delivery Order
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order worth $28,502.07 to Amerisourcebergen Drug Corp, a subsidiary of parent company Cencora, Inc. The order is for the supply of 4,564,261,702 units of the medication Tobramycin 300 mg/4 ml ampules. The delivery order has an ultimate completion date of April 15, 2024. Amerisourcebergen Drug Corp, as a prime contractor, also holds an indefinite delivery contract (IDC) with DLA worth up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to provide pharmaceuticals and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this specific delivery order.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $28.5k | 4/12/24 |